K9MD's detector dogs ready to sniff out ovarian cancer
Early trials have shown medical detection dogs picking up ovarian cancer with an incredible accuracy. Two of K9 Medical ...
Targeted Oncology21h
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...
The Manila Times21h
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...
HC Wainwright Reaffirms “Buy” Rating for Candel Therapeutics (NASDAQ:CADL)
Candel Therapeutics (NASDAQ:CADL – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued to investors on Friday,Benzinga reports.
CURE18h
Ongoing Trials Aim to Advance HER2-Negative Breast Cancer Treatment
Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...
Novel cancer therapy works for 73 per cent Indian patients in clinical trials: Why the Lancet report is significant
The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 ...